TORL Biotherapeutics, LLC clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   TORL-4-500 · Advanced Cancer

   Primary completion pushed from Oct 31, 2025 to Mar 29, 2027

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Oct 31, 2026 to May 31, 2027

   TORL Biotherapeutics, LLC·Phase 1· NCT06005740· Registry history of NCT06005740 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.